This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tedla, N. Articles by Arm, J. P. Search for Related Content PubMed PubMed Citation Articles by Tedla, N. Articles by Arm, J. P.

(American Journal of Pathology. 2002;160:425-431.)
© 2002 American Society for Investigative Pathology

Short Communications

The Co-Expression of Activating and Inhibitory Leukocyte Immunoglobulin-Like Receptors in Rheumatoid Synovium

Nicodemus Tedla^*, Kathryn Gibson, H. Patrick McNeil, David Cosman, Luis Borges and Jonathan P. Arm^*

From the Division of Rheumatology, Immunology, andAllergy,^*
Brigham and Women’s Hospital, and the Departmentof Medicine, Harvard Medical School, Boston, Massachusetts; the Schoolof Pathology,
Inflammation Research Unit,University of New South Wales, Sydney, Australia; and the ImmunexCorporation,
Seattle, Washington

Rheumatoid arthritis (RA) is a chronic inflammatory synovitis, with destruction of juxtaarticular cartilage and bone, likely mediated by lipid mediators, cytokines, and proteases released from inflammatory leukocytes. The mechanisms regulating leukocyte activation in rheumatoid synovium are not fully elucidated. A new family of cell surface proteins termed leukocyte immunoglobulin-like receptors (LIRs) has been shown in vitro to modulate cellular responses through immunoreceptor tyrosine-based inhibitory motifs or through association with the Fc receptor chain that contains immunoreceptor tyrosine-based activation motifs. We studied the expression of inhibitory and activating LIRs in the synovium of six RA patients, three osteoarthritis patients, and three controls by immunohistochemistry. The synovium from patients with early RA showed extensive expression of the inhibitory LIR-2 and the activating LIR-7 on macrophages and neutrophils. Some mast cells and endothelial cells expressed LIR-7. There was limited expression of LIRs in synovium from two patients with long-standing RA, patients with osteoarthritis, and controls. LIR-2 recognizes MHC class I molecules. We therefore suggest that LIRs may regulate the activation of infiltrating leukocytes in synovial tissue and are a potential therapeutic target.

This article has been cited by other articles:

				N. Tedla, C.-W. Lee, L. Borges, C. L. Geczy, and J. P. Arm Differential expression of leukocyte immunoglobulin-like receptors on cord blood-derived human mast cell progenitors and mature mast cells J. Leukoc. Biol., February 1, 2008; 83(2): 334 - 343. [Abstract] [Full Text] [PDF]

				S. Ochi, M. Shinohara, K. Sato, H.-J. Gober, T. Koga, T. Kodama, T. Takai, N. Miyasaka, and H. Takayanagi Pathological role of osteoclast costimulation in arthritis-induced bone loss PNAS, July 3, 2007; 104(27): 11394 - 11399. [Abstract] [Full Text] [PDF]

				O. A. Huynh, T. Hampartzoumian, J. P. Arm, J. Hunt, L. Borges, M. Ahern, M. Smith, C. L. Geczy, H. P. McNeil, and N. Tedla Down-regulation of leucocyte immunoglobulin-like receptor expression in the synovium of rheumatoid arthritis patients after treatment with disease-modifying anti-rheumatic drugs Rheumatology, May 1, 2007; 46(5): 742 - 751. [Abstract] [Full Text] [PDF]

				M. Shiroishi, K. Kuroki, L. Rasubala, K. Tsumoto, I. Kumagai, E. Kurimoto, K. Kato, D. Kohda, and K. Maenaka Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d) PNAS, October 31, 2006; 103(44): 16412 - 16417. [Abstract] [Full Text] [PDF]

				N. Di Girolamo, I. Indoh, N. Jackson, D. Wakefield, H. P. McNeil, W. Yan, C. Geczy, J. P. Arm, and N. Tedla Human Mast Cell-Derived Gelatinase B (Matrix Metalloproteinase-9) Is Regulated by Inflammatory Cytokines: Role in Cell Migration J. Immunol., August 15, 2006; 177(4): 2638 - 2650. [Abstract] [Full Text] [PDF]

				B. D. Wines, H. M. Trist, P. A. Ramsland, and P. M. Hogarth A Common Site of the Fc Receptor {gamma} Subunit Interacts with the Unrelated Immunoreceptors Fc{alpha}RI and Fc{epsilon}RI J. Biol. Chem., June 23, 2006; 281(25): 17108 - 17113. [Abstract] [Full Text] [PDF]

				K. Kuroki, N. Tsuchiya, M. Shiroishi, L. Rasubala, Y. Yamashita, K. Matsuta, T. Fukazawa, M. Kusaoi, Y. Murakami, M. Takiguchi, et al. Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis Hum. Mol. Genet., August 15, 2005; 14(16): 2469 - 2480. [Abstract] [Full Text] [PDF]

				D. E. Sloane, N. Tedla, M. Awoniyi, D. W. MacGlashan Jr, L. Borges, K. F. Austen, and J. P. Arm Leukocyte immunoglobulin-like receptors: novel innate receptors for human basophil activation and inhibition Blood, November 1, 2004; 104(9): 2832 - 2839. [Abstract] [Full Text] [PDF]

				M. Shiroishi, K. Tsumoto, K. Amano, Y. Shirakihara, M. Colonna, V. M. Braud, D. S. J. Allan, A. Makadzange, S. Rowland-Jones, B. Willcox, et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G PNAS, July 22, 2003; 100(15): 8856 - 8861. [Abstract] [Full Text] [PDF]

				L. Borges, M. Kubin, and T. Kuhlman LIR9, an immunoglobulin-superfamily-activating receptor, is expressed as a transmembrane and as a secreted molecule Blood, February 15, 2003; 101(4): 1484 - 1486. [Abstract] [Full Text] [PDF]

				N. Tedla, C. Bandeira-Melo, P. Tassinari, D. E. Sloane, M. Samplaski, D. Cosman, L. Borges, P. F. Weller, and J. P. Arm Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7 PNAS, February 4, 2003; 100(3): 1174 - 1179. [Abstract] [Full Text] [PDF]